How to Approach a Patient with Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?

The use of 18 F-fluorodeoxyglucose positron emission tomography with computerized tomography (FDG-PET/CT), has emerged as a crucial tool for response-adapted therapy in Hodgkin lymphoma (HL). Although more studies have focused on the predictive value of an interim or early PET obtained after 2 cycles of chemotherapy, there are indications that the end of therapy PET may even be more predictive of outcome. The optimal treatment of patients with limited stage HL who are PET positive after chemotherapy is unknown.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Review Article Source Type: research